Evidence map›Paper›PMID 36811731›Full record

ArticleThe Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology2023

Interventional therapy of acute coronary syndromes in very old patient population and results of 2 years follow-up.

Bedrettin Boyraz, Tezcan Peker, Alkame Akgümüş, Ahmet Balun

Open access · diamondAbstract read
In one paragraph

Article in The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Bedrettin BoyrazCardiology Department, Medicalpark Hospital, Mudanya University, Kırcaali, Fevzi Çakmak Cd. No:76, 16220, Osmangazi, Bursa, Turkey. bedrettinboyraz@yahoo.com.ORCID http://orcid.org/0000-0003-1831-182X
Tezcan PekerCardiology Department, Medicalpark Hospital, Mudanya University, Kırcaali, Fevzi Çakmak Cd. No:76, 16220, Osmangazi, Bursa, Turkey.
Alkame AkgümüşCardiology Department, Medical Faculty, Bandırma Onyedi Eylül University, Balıkesir, Turkey.
Ahmet BalunCardiology Department, Medical Faculty, Bandırma Onyedi Eylül University, Balıkesir, Turkey.
Bandırma Onyedi Eylül University · TRGazi Hastanesi · TRMudanya Üniversitesi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResearch on cardiovascular treatment options and prognosis in very old age groups of patients is warranted. In our study, we evaluated and followed up on clinical conditions on admission and comorbidities of patients older than 80 years who were admitted to our hospital with acute myocardial infarction and shared our findings.

resultsA total of 144 patients were included in the study, with a mean age of 84.56 ± 5.01 years. No complications resulting in death or requiring surgery were observed in the patients. All-cause mortality was found to be related to heart failure, chronic pulmonary disease shock, and C-reactive protein levels. Cardiovascular mortality was correlated to heart failure, shock on admission, and C-reactive protein levels. No significant difference in mortality was observed between Non-ST elevated myocardial infarction and ST-elevation myocardial infarction.

conclusionsPercutaneous coronary intervention is a safe treatment option with low complication and mortality rates in very old patients with acute coronary syndromes.

Indexed as

Acute coronary syndromeInterventional theraphyTwo years follow-upVery old patient population

Identifiers

PMID36811731
PMCPMC9947199
OpenAlexW4321489953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.